| Industry | 批发和零售业 | ||||||||||||||||||||||||
| Company Introduction | 湖南达嘉维康医药股份有限公司总部座落在长沙市岳麓高新区，占地面积85亩，其中办公面积2.5万平方米，仓储面积3万平方米，是一个集产学研一体的创新型医药企业。经过近二十年在医药健康领域的深耕细作，公司逐步形成“以药品批发和零售业务为核心，产业链延伸业务为补充”的综合性医药业务体系。公司以诚信赢客户，以创新拓市场，在医院销售、终端市场占有、零售业务、特门销售等领域均取得了骄人的业绩。2020年总销售收入30亿元，上缴税收1亿余元。公司是国家发改委生物医药物流配送重点支持企业、国家4A级医药物流企业、湖南省重点医药储备企业、湖南省公共卫生应急物资承储企业、中国医药物流行业模范单位、湖南省医药行业协会副会长单位，多次被评为“年度守信用企业”。公司目前已发展成湖南省医药行业龙头企业之一。公司拥有集特门、特药、DTP及院外处方流转为一体的专业药房，是湖南省首家特殊病种和大病医保定点药房，是湖南省第一家DTP（患者直达服务）业务的药房，服务全省上十万慢病患者。公司荣获“2019年度十大DTP药房”、“2020年优秀DTP专业药房”、2021年荣获“最具投资价值拟上市医药企业”奖、“最具社会责任医药企业”奖等多项荣誉。公司秉承“关注健康、服务人民”的服务宗旨。2011年5月，公司成立“湖南省急救药品配送服务中心”，为全省的医疗机构提供应急抢救、短缺药品配送服务。为提升公司的核心竞争力，不断完善健康产业链，2019年长沙嘉辰生殖与遗传专科医院试营业，现设有内分泌科、妇科、遗传医学专科、生殖健康与不孕科、男性专科等科室。未来将以人工辅助生育和遗传专科为核心开展学科建设和医疗服务。2021年2月公司在深圳证券交易所创业板IPO成功过会，为公司的快速发展创造了更好的平台。 | ||||||||||||||||||||||||
| Main Business | 药品、生物制品、医疗器械等产品的分销及零售业务。 | ||||||||||||||||||||||||
| Legal Representative | 王毅清 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 蒋茜 | ||||||||||||||||||||||||
| Solicitors | 上海市通力律师事务所 | ||||||||||||||||||||||||
| Auditors | 天健会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0731-84170075 | ||||||||||||||||||||||||
| Fax No | 0731-88911758 | ||||||||||||||||||||||||
| Website | www.djwk.com.cn | ||||||||||||||||||||||||
| djwkzqb@djwk.com.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 07/12/2021 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.170 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.040 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 8.461 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 1.321B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |